Bionical Revenue and Competitors

Hillsborough, NJ USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bionical's estimated annual revenue is currently $69.9M per year.(i)
  • Bionical's estimated revenue per employee is $201,000

Employee Data

  • Bionical has 348 Employees.(i)
  • Bionical grew their employee count by 8% last year.

Bionical's People

NameTitleEmail/Phone
1
Chief Technology OfficerReveal Email/Phone
2
VP, Creative ServicesReveal Email/Phone
3
VP, Business DevelopmentReveal Email/Phone
4
SVP Strategic AccountsReveal Email/Phone
5
VP OperationsReveal Email/Phone
6
Head HealthWareReveal Email/Phone
7
Head Products & Services Development - Bionical DigitalReveal Email/Phone
8
Head Business IntelligenceReveal Email/Phone
9
Head InsightsReveal Email/Phone
10
VP Business DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is Bionical?

Bionical provides high quality clinical, commercial and communications services to pharmaceutical, biotech and public health companies in the global healthcare industry.With a mission to improve health outcomes, Bionical's services accelerate product and treatment development and enhance communication and engagement with healthcare professionals and patients.

keywords:N/A

N/A

Total Funding

348

Number of Employees

$69.9M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bionical News

2022-03-22 - Ian Fraser appointed as EVP Clinical Development

Bionical Emas is a global Contract Research Organisation (CRO) business which combines clinical development, early access program and clinical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$130.5M460-38%N/A
#2
$168.6M46532%N/A
#3
$115M5117%N/A
#4
$110.4M62111%$409M
#5
$94.7M631-26%N/A